Archives of Dermatology · 2007 · 67 citations · 18 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsPediatric GeneticsCongenital AnomaliesCongenital DisordersDysplasiaGenetic DisordersGenetic SyndromesMendelian DisordersDevelopmental Delay GeneticsFgfr3-related DisordersFibroblast Growth Factor Receptor 3 (Fgfr3) DisordersFibroblast Growth Factor Receptor AlterationsShort Stature GeneticsSkeletal Dysplasia GeneticsThanatophoric Skeletal Dysplasia
BACKGROUND: Acanthosis nigricans is a feature of several syndromes caused by activating mutations of the fibroblast growth factor receptor 3 gene (FGFR3), including Crouzon syndrome with acanthosis nigricans, thanatophoric dysplasia, and severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN syndrome). OBSERVATIONS: We describe a healthy 4-year-old African American girl with generalized acanthosis nigricans since infancy. Her father had a history of acanthosis nigricans since childhood, in addition to Crohn disease, obesity, and adult-onset diabetes mellitus. A pedigree with numerous affected family members was constructed. Other than slightly short stature, no associated anomalies were found, including dysmorphic features or skeletal or neurologic defects. Genetic testing revealed a previously undescribed, heterozygous lysine to threonine mutation at codon 650 of the FGFR3 gene in the 4 affected family members who were tested. CONCLUSION: Extensive acanthosis nigricans in early childhood, especially with a family history of acanthosis nigricans, may warrant testing for FGFR3 mutations.
18
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
David Cappellen, Catherine De Oliveira, David Ricol et al. · Nature Genetics · 1999 · 705 citations
Gary A. Bellus, Elaine Spector, Phyllis Speiser et al. · The American Journal of Human Genetics · 2000 · 172 citations · Full text